SYNTHEKINE
Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. Using the principles of cytokine partial agonism and immunological specificity, Synthekine designs differentiated therapeutics to be both safe and efficacious. Its lead programs have shown promising efficacy and tolerability in preclinical studies, and it is developing additional cytokine partial agonists that selectively modulate key pathways of the immune system.
SYNTHEKINE
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.synthekine.com
Total Employee:
11+
Status:
Active
Contact:
(650) 271-9888
Total Funding:
189.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Sitelinks Search Box
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
RA Capital Management
RA Capital Management investment in Series B - Synthekine
Rock Springs Capital
Rock Springs Capital investment in Series B - Synthekine
Deerfield
Deerfield investment in Series B - Synthekine
The Column Group
The Column Group investment in Series B - Synthekine
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Synthekine
Omega Funds
Omega Funds investment in Series B - Synthekine
Canaan Partners
Canaan Partners investment in Series B - Synthekine
Samsara BioCapital
Samsara BioCapital investment in Series B - Synthekine
TCG Crossover
TCG Crossover investment in Series B - Synthekine
Emerson Collective
Emerson Collective investment in Series B - Synthekine
Official Site Inspections
http://www.synthekine.com Semrush global rank: 4.48 M Semrush visits lastest month: 2.41 K
Unable to get host informations!!!
